Gilead stock surges 15% after report says coronavirus drug trial shows encouraging early results


A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018.

Stephen Lam | Reuters

Gilead Sciences shares surged by more than 15% in after-hours trading Thursday after an industry publication said Covid-19 patients being treated with the company’s antiviral drug Remdesivir appear to have “rapid recoveries in fever and respiratory symptoms.” 

STAT News said a doctor in Chicago overseeing a closely watched clinical trial on the drug found that most of its patients had been discharged in less than a week. 

“The best news is that most of our patients have already been discharged, which is

Read More

GM encouraging suppliers to produce face masks amid COVID-19 pandemic


General Motors Chairman and CEO Mary Barra on April 1, 2020 tours one of the company’s facilities in Warren, Michigan that will produce Level 1 face masks.


General Motors is encouraging and empowering its suppliers to assist in production of medical face masks for frontline workers amid the coronavirus pandemic.

In a note to the suppliers on Saturday, Shilpan Amin, GM’s vice president of global purchasing and supply chain, said it is making the automaker’s step-by-step manufacturing plans for the personal protective equipment available to any company willing to join in the cause.

“Our ultimate goal is to get

Read More